Surajit Pal of Prabhudas Lilladher feels the pharma company's US sales will take atleast 18 months to recover. He fears that if USFDA issue is raised then UK MHRA too may act.
first published: Nov 5, 2014 10:17 am
A collection of the most-viewed Moneycontrol videos.
Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
Live: Can Nifty reach its all-time high levels this week? | Opening Bell
This Tenant says Andheri West is better than SOBO | The tenant
Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
